ONOnconetix, Inc. ONCO · NASDAQ
$0.42 +4.29% (+$0.02)
- Market cap
- $1.44M
- Enterprise value
- -$4.32M
- P/E
- -
- Forward P/E
- -
- PEG
- -
- P/S
- 2.2x
- P/FCF
- -
- EV/EBITDA
- -
- ROIC
- -59.9%
- Bruto marža
- 80.4%
- Neto marža
- -1,578.8%
- Dividend yield
- -
- Payout ratio
- -
- Neto dolg/EBITDA
- -
- Beta
- 2.61
- Free float
- 32.0%
O podjetju
Onconetix, Inc. is a commercial stage biotechnology company, which engages in the research, development and commercialization of proprietary therapeutics, diagnostics and services for clinicians and patients for oncology. The company was founded in October 2018 and is headquartered in Cincinnati, OH.
Sector
Healthcare
Industry
Biotechnology
CEO
David Allan White
Employees
2
Headquarters
Cincinnati
Vrednotenje
Je današnja cena primerna?
Rast in ocene
Ali podjetje raste in kaj sledi?
Donosnost in kakovost
Koliko prihodkov ostane in kako dobro podjetje uporablja kapital?
Finančno zdravje
Ali zmore svoj dolg?
Kapital in dividende
Kaj podjetje počne z zasluženim denarjem?
Analitiki
Kaj menijo strokovnjaki in ali se to spreminja?
Lastniki in insajderji
Kdo ima delnice in kaj počne vodstvo?
Segmenti
Kateri del podjetja raste?
Primerjava s konkurenco
Kako se primerja s podobnimi podjetji?
Cena in tveganje
Kako se delnica obnaša?
Izkazi
Vse številke